Source: NS Medical Devices

ABK Biomedical: ABK Biomedical treats first patient in Eye90 microspheres trial in HCC

The post ABK Biomedical treats first patient in Eye90 microspheres trial in HCC appeared first on NS Medical Devices.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael Mangano's photo - President & CEO of ABK Biomedical

President & CEO

Michael Mangano

CEO Approval Rating

90/100

Read more